Published in Gene Therapy Weekly, October 11th, 2001
"The use of pyrazinamide (PZA) is important for the treatment of Mycobacterium tuberculosis as it is bactericidal to semi-dormant mycobacteria that are not affected by other drugs," explained K.S. Bishop and colleagues at the University of Natal in Durban and the SAIMR Tuberculosis Reference Laboratory in Gauteng. However, "incidence of resistance to PZA and other drugs used in the treatment of M. tuberculosis is increasing in South Africa."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly